In 2006 SGI raised its Series A round of financing from Draper Fisher Jurvetson, Meteor Group, Biotechonomy LLC and Plenus, S.A. de C.V. In 2007 SGI closed its Series B round of financing with BP plc and ACGT Sdn Bhd. In 2010 Life Technologies joined SGI as an investor followed by Lung Biotechnology, Inc. (a subsidiary of United Therapeutics Corporation) in 2014.

For more information, please email